Sorrento Therapeutics Logo Image

Sorrento Therapeutics

Sorrento Therapeutics has reached its limit for report views.

Please check back to see if Sorrento Therapeutics has upgraded their profile page to allow their financial information to be viewed. In the meantime, here are a few annual reports from similar companies.

Most Recent Annual Report

2016 Annual Report and Form 10K

Sorrento Therapeutics

Sorrento Therapeutics does not currently have any hardcopy reports available on AnnualReports.com. Click the button below to be notified when hardcopies become available.



Archived Annual Reports

  • Sorrento Therapeutics
  • Sorrento Therapeutics
  • Sorrento Therapeutics

About Sorrento Therapeutics

51-200 Employees
Based in San Diego, California

Sorrento Therapeutics is an antibody-centric, clinical stage biopharmaceutical company developing new treatments for cancer, inflammation and autoimmune diseases. Sorrento's lead products are multiple late-stage biosimilar and biobetter antibodies, as well as clinical CAR-T therapies targeting solid tumors.

Ticker:
SRNE
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol